Compare ARK Fintech Innovation ETF (ARKF) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Fintech Innovation ETF vs Novo Nordisk A/S — how do they compare? ARK Fintech Innovation ETF trades at $42.86, while Novo Nordisk A/S trades at $46.02 (market cap $207.85B). The key difference: Novo Nordisk A/S pays a 3.81% dividend while ARK Fintech Innovation ETF pays none. Which is the better fit depends on your goals.
| ARKF | NVO | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $58.82 | $63.98 |
52-Week Low | $36.14 | $35.29 |
Market Cap | — | $207.85B |
Enterprise Value | — | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Fintech Innovation ETF
ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.
Read more on ARKF →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
